These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22257418

  • 1. Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy.
    Yoshida M, Asai M, Miyata M, Ogawa K, Maeda H, Oiso Y.
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e55-6. PubMed ID: 22257418
    [No Abstract] [Full Text] [Related]

  • 2. Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results.
    Jendle J, Torffvit O, Ridderstråle M, Ericsson Å, Nilsen B, Bøgelund M.
    J Med Econ; 2012 Jun; 15 Suppl 2():1-5. PubMed ID: 22853443
    [Abstract] [Full Text] [Related]

  • 3. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
    Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D.
    Prim Care Diabetes; 2010 Jul; 4(2):113-7. PubMed ID: 20444662
    [Abstract] [Full Text] [Related]

  • 4. Insulin treatment for type 2 diabetes: when to start, which to use.
    Hamaty M.
    Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
    [Abstract] [Full Text] [Related]

  • 5. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E, Sesti G.
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [Abstract] [Full Text] [Related]

  • 6. Liraglutide: from clinical trials to clinical practice.
    Gough SC.
    Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
    [Abstract] [Full Text] [Related]

  • 7. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.
    Ryan GJ, Hardy Y.
    J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609
    [Abstract] [Full Text] [Related]

  • 8. Multiple drug combination of anti-diabetic agents as a predictor for poor clinical response to liraglutide.
    Haraguchi A, Fujishima K, Ando T, Mori F, Imaizumi M, Abiru N, Yamasaki H, Matsumoto K, Takamura N, Kawakami A.
    Minerva Endocrinol; 2014 Dec; 39(4):289-97. PubMed ID: 25371055
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm.
    Unger J.
    J Am Osteopath Assoc; 2011 Feb; 111(2 Suppl 1):eS2-9. PubMed ID: 21389296
    [Abstract] [Full Text] [Related]

  • 10. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E, Sausele T.
    Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 12. [Liraglutide in the treatment of diabetes type 2].
    Novak B, Metelko Z.
    Lijec Vjesn; 2011 Feb 12; 133(7-8):269-76. PubMed ID: 22165195
    [Abstract] [Full Text] [Related]

  • 13. Incretin therapy and its effect on body weight in patients with diabetes.
    Lind M.
    Prim Care Diabetes; 2012 Oct 12; 6(3):187-91. PubMed ID: 22613745
    [Abstract] [Full Text] [Related]

  • 14. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE.
    Endocrinol Metab Clin North Am; 2007 Dec 12; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract] [Full Text] [Related]

  • 15. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J.
    Nihon Rinsho; 2002 Sep 12; 60 Suppl 9():442-6. PubMed ID: 12387031
    [No Abstract] [Full Text] [Related]

  • 16. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
    Halimi S.
    Diabetes Metab; 2008 Feb 12; 34 Suppl 2():S91-5. PubMed ID: 18640591
    [Abstract] [Full Text] [Related]

  • 17. Liraglutide in oral antidiabetic drug combination therapy.
    Garber AJ.
    Diabetes Obes Metab; 2012 Apr 12; 14 Suppl 2():13-9. PubMed ID: 22405265
    [Abstract] [Full Text] [Related]

  • 18. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes].
    Fabreegas B.
    Soins; 2008 Jun 12; (726):34-7. PubMed ID: 18697336
    [No Abstract] [Full Text] [Related]

  • 19. Current challenges in type 2 diabetes.
    Garber AJ.
    Diabetes Obes Metab; 2012 Apr 12; 14 Suppl 2():1-3. PubMed ID: 22405263
    [No Abstract] [Full Text] [Related]

  • 20. Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China.
    Gao L, Zhao FL, Li SC.
    Int J Technol Assess Health Care; 2012 Oct 12; 28(4):436-44. PubMed ID: 23006540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.